In last trading session, RxSight Inc (NASDAQ:RXST) saw 1.24 million shares changing hands with its beta currently measuring 1.22. Company’s recent per share price level of $13.31 trading at $0.07 or 0.53% at ring of the bell on the day assigns it a market valuation of $540.87M. That closing price of RXST’s stock is at a discount of -384.6% from its 52-week high price of $64.50 and is indicating a premium of 5.86% from its 52-week low price of $12.53.

For RxSight Inc (RXST), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.36. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.04 in the current quarter.

RxSight Inc (NASDAQ:RXST) trade information

Upright in the green during last session for gaining 0.53%, in the last five days RXST remained trading in the green while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $13.31 price level, adding 7.31% to its value on the day. RxSight Inc’s shares saw a change of -61.29% in year-to-date performance and have moved 0.60% in past 5-day. RxSight Inc (NASDAQ:RXST) showed a performance of -8.96% in past 30-days.

Wall Street analysts have assigned a consensus price target of 67 to the stock, which implies a rise of 80.13% to its current value. Analysts have been projecting 52 as a low price target for the stock while placing it at a high target of 110. It follows that stock’s current price would drop -290.68% in reaching the projected high whereas dropping to the targeted low would mean a loss of -290.68% for stock’s current value.

RxSight Inc (RXST) estimates and forecasts

This year revenue growth is estimated to rise 19.75% from the last financial year’s standing.

10 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 39.78M for the same. And 10 analysts are in estimates of company making revenue of 40.54M in the next quarter. Company posted 34.89M and 35.31M of sales in current and next quarters respectively a year earlier.

In 2025, company’s earnings growth rate is likely to be around 2.68% while estimates for its earnings growth in next 5 years are of 25.43%.

RxSight Inc (NASDAQ:RXST)’s Major holders

RA CAPITAL MANAGEMENT, L.P. is the top institutional holder at RXST for having 3.69 million shares of worth $222.32 million. And as of 2024-06-30, it was holding 9.6079 of the company’s outstanding shares.

The second largest institutional holder is BLACKROCK INC., which was holding about 2.4 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.2421 of outstanding shares, having a total worth of $144.44 million.

On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Artisan Partners Funds Inc.-Artisan International Small-Mid Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024, the former fund manager was holding 1.1 shares of worth $14.59 million or 2.70% of the total outstanding shares. The later fund manager was in possession of 1.02 shares on Dec 31, 2024, making its stake of worth around $13.63 million in the company or a holder of 2.52% of company’s stock.